BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17979589)

  • 1. Initiation and change of psychotropic medication regimens among adolescents in inpatient care.
    Warner LA; Fontanella CA; Pottick KJ
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):701-12. PubMed ID: 17979589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
    Fontanella CA; Bridge JA; Campo JV
    Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
    Martin A; Leslie D
    Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic medication utilization in a child and adolescent mental health service.
    Dean AJ; McDermott BM; Marshall RT
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):273-85. PubMed ID: 16768635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication history of inpatient adolescents--is there a rationale for benzodiazepine prescription?
    Ilomäki R; Ilomäki E; Hakko H; Räsänen P
    Addict Behav; 2011; 36(1-2):161-5. PubMed ID: 21035951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of mental health service use among Medicaid-insured youths treated by nurse practitioners and physicians: A retrospective cohort study.
    Yang BK; Idzik S; Evans P
    Int J Nurs Stud; 2021 Aug; 120():103956. PubMed ID: 34091256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant psychotropic medication for youths.
    Safer DJ; Zito JM; DosReis S
    Am J Psychiatry; 2003 Mar; 160(3):438-49. PubMed ID: 12611822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of admission to acute inpatient psychiatric care among children enrolled in Medicaid.
    Bryson SA; Akin BA
    Adm Policy Ment Health; 2015 Mar; 42(2):197-208. PubMed ID: 24841746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Medicaid eligibility category on racial disparities in the use of psychotropic medications among youths.
    Zito JM; Safer DJ; Zuckerman IH; Gardner JF; Soeken K
    Psychiatr Serv; 2005 Feb; 56(2):157-63. PubMed ID: 15703342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic prescription practices in child psychiatric inpatients 9 years old and younger.
    Lekhwani M; Nair C; Nikhinson I; Ambrosini PJ
    J Child Adolesc Psychopharmacol; 2004; 14(1):95-103. PubMed ID: 15142396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in psychotropic drug use in a child psychiatric hospital from 1991-1998.
    Najjar F; Welch C; Grapentine WL; Sachs H; Siniscalchi J; Price LH
    J Child Adolesc Psychopharmacol; 2004; 14(1):87-93. PubMed ID: 15142395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of Mental Health Service Use Among Young Adults With Mental Illness: Results From the National Survey on Drug Use and Health.
    Miller S; Ringeisen H; Munoz B; Hedden SL; Colpe LJ; Rohloff H; Embry V
    Psychiatr Serv; 2016 Jun; 67(6):642-9. PubMed ID: 27079984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M; Lannon P; Roohan P; Gesten F
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment.
    Connor DF; Ozbayrak KR; Harrison RJ; Melloni RH
    J Child Adolesc Psychopharmacol; 1998; 8(1):27-38. PubMed ID: 9639077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the use of health care and special school services, prior to admission for psychiatric inpatient treatment, differ between adolescents housed by child welfare services and those living with their biological parent(s)?
    Laukkanen M; Hakko H; Räsänen P; Riala K
    Community Ment Health J; 2013 Oct; 49(5):528-39. PubMed ID: 23392732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison.
    Barbui C; Ciuna A; Nosè M; Levi D; Andretta M; Patten SB; Amaddeo F; Tansella M
    Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):136-42. PubMed ID: 15812608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric diagnosis and psychotropic medication prescription patterns in a mental hospital-based child and adolescent psychiatric service in Nigeria.
    Bakare MO; Igwe MN; Odinka PC; Iteke O
    J Health Care Poor Underserved; 2011 Aug; 22(3):751-5. PubMed ID: 21841276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication use in US youth with mental disorders.
    Merikangas KR; He JP; Rapoport J; Vitiello B; Olfson M
    JAMA Pediatr; 2013 Feb; 167(2):141-8. PubMed ID: 23403911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.